Nyremedicinsk Afdeling

Medicine and Dentistry

1. Patient 100%
2. Inpatient 38%
3. Therapeutic Procedure 35%
4. Chronic Kidney Disease 33%
5. Cohort Analysis 23%
6. Placebo 22%
7. Hyponatremia 18%
8. Hemodialysis 18%
9. Amaurosis 16%
10. Supplementation 15%
11. Kidney Graft 12%
12. Cardiovascular System 12%
13. Age 12%
14. Arterial Stiffness 12%
15. Mortality 11%
16. ANCA Associated Vasculitis 11%
17. Vitamin 11%
18. Glomerular Filtration Rate 10%
19. Analysis 10%
20. Eculizumab 10%
21. Irbesartan 9%
22. Blood Pressure 9%
23. Heart Failure 9%
24. Hazard Ratio 9%
25. Cardiovascular Disease 8%
26. Transplantation 8%
27. Omega-3 Fatty Acid 8%
28. Bone Density 8%
29. End Stage Renal Disease 8%
30. Follow up 8%
31. Bone Turnover 7%
32. Biological Marker 7%
33. Protein 7%
34. Child 7%
35. Atypical Hemolytic Uremic Syndrome 7%
36. Cannulation 7%
37. Kidney Denervation 7%
38. PET-CT 7%
39. Fluorine-18 7%
40. Immunoglobulin A Nephropathy 7%
41. Anticoagulation 7%
42. Association 7%
43. Kidney Transplantation 7%
44. Apoplexy 6%
45. Sodium 6%
46. Assessment 6%
47. Heart Rate Variability 6%
48. Diseases 6%
49. Systolic Blood Pressure 6%
50. Angiotensin Receptor Antagonist 6%
51. Measurement 6%
52. Kidney Function 6%
53. Diabetes 5%
54. Diagnosis 5%
55. Death 5%
56. Serum 5%
57. Hypertension 5%
58. Drug Therapy 5%
59. Essential Hypertension 5%
60. Atrial Fibrillation 5%
61. Adult 5%